News & Insight

21 April 2021
News
Caitlin Brennan discusses the microbiome and aspirin's potential in personalised prevention
Caitlin Brennan
New findings from the OPTIMISTICC team reveal aspirin’s antibacterial activity against Fusobacterium nucleatum, an oncomicrobe known to drive colorectal cancer.   OPTIMISTICC’s Caitlin Brennan, postdoctoral fellow and microbiologist at …

Latest

News
15 April 2021
By distinguishing between people with ductal carcinoma in situ (DCIS) who will develop invasive breast cancer and those who won’t, the Cancer Grand…
Video
13 April 2021
Look inside the IMAXT team’s virtual reality lab, ahead of its release later this year, as the team calls for volunteers to help test the software…
Blog
31 March 2021
Findings from the OPTIMISTICC team point towards a global microbiome signature for colorectal cancer that could help improve the way we detect the…
Blog
30 March 2021
In October, we posed 9 new challenges to the research community, each with the potential to change the way we think about cancer. Through our blog…

Latest tweet

Congratulations to Peter Campbell from our Mutographs team on being elected a Fellow @royalsociety for his outstand… https://t.co/OcnIjiefFk Mon May 10 09:23:11 +0000 2021

News and insight archive

Format
Choose
Team
Choose
Tags
Choose
News
New findings from the OPTIMISTICC team reveal aspirin’s antibacterial activity against Fusobacterium nucleatum, an oncomicrobe known to drive colorectal cancer.   OPTIMISTICC’s Caitlin Brennan, postdoctoral fellow and…
21 April 2021
News
By distinguishing between people with ductal carcinoma in situ (DCIS) who will develop invasive breast cancer and those who won’t, the Cancer Grand Challenges PRECISION team could spare thousands of women around the…
15 April 2021
Video
Look inside the IMAXT team’s virtual reality lab, ahead of its release later this year, as the team calls for volunteers to help test the software.   A core component of the Cancer Grand Challenges IMAXT programme,…
13 April 2021
Blog
Findings from the OPTIMISTICC team point towards a global microbiome signature for colorectal cancer that could help improve the way we detect the disease. Colorectal cancer is the third most common cancer in the world…
31 March 2021
Blog
In October, we posed 9 new challenges to the research community, each with the potential to change the way we think about cancer. Through our blog series, members of our Cancer Grand Challenges Scientific Committee…
30 March 2021
Video
We recently held a webinar with the American Association for Cancer Research (AACR) providing an overview of the Cancer Grand Challenges partnership between Cancer Research UK and the US National Cancer Institute. …
30 March 2021
News
New findings from the Cancer Grand Challenges PRECISION team suggest adipocyte size and COX2 expression could help to identify which people with ductal carcinoma in situ (DCIS) are at high-risk of developing invasive…
22 March 2021
Blog
Patient advocate Candace Henley and physician-scientist Kimmie Ng are members of the Cancer Grand Challenges OPTIMISTICC team. Together they have helped to set up the programme's flagship study, MICROCOSM.  An…
11 March 2021
News
Amy Schade joined Karen Cichowski’s lab (Brigham and Women's Hospital, Harvard Medical School) as a postdoctoral research fellow in 2019. Karen is Amy’s mentor, and both are part of the Cancer Grand Challenges…
10 March 2021